Project overview

Ensemble along with its partner Gatusso Development Partners developed this  137,000 SF class A build-to-suit office/lab building for Iovance Biotheraputics in the Philadelphia Navy Yard.  The single-tenant building was designed to meet the functional requirements of Iovance, while offering adaptability for future expansion.

Iovance Biotherapeutic, a biopharmaceutical company, will manufacture their lead product – an autologous, ready-to-infuse cell therapy that has demonstrated distinctive efficacy in the treatment of metastatic melanoma. The facility includes aseptic cell therapy manufacturing, analytical labs, training and process development rooms, and general office functions.